Bar Plot from Scientific Research

Relative change from baseline in MRI-PDFF (placebo, n = 21; TERN-501 1 mg, n = 23 (P = 0.1303); TERN-501 3 mg, n = 19 (P = 0.0036); TERN-501 6 mg, n = 18 (P < 0.0001)) at week 12 for TERN-501 monotherapy groups. Statistical analysis was performed using a type III sum of squares ANCOVA model with treatment group as a fixed effect and baseline value as the covariate; comparison between groups was conducted at the two-sided, 0.05 level of significance. No adjustments for multiplicity were made. **P < 0.01; ***P < 0.001 for TERN-501 monotherapy versus placebo. Error bars, s.e.

DOI